-

Trinity Life Sciences Announces the Appointment of Paul R. Lucchese as General Counsel

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a global leader in life sciences solutions, today announced the appointment of Paul R. Lucchese as General Counsel and a member of the executive operating committee, reporting directly to Rebecca McNamara, Trinity’s Chief Financial Officer and Head of Corporate Operations. He will be responsible for leading Trinity’s legal operations and global compliance activities.

Mr. Lucchese has extensive experience as a General Counsel in high-growth technology-forward organizations including Aspect Software, Candela Corporation, Aternity, Inc. and EnterpriseDB. He also was the President of Outsourced General Counsel, a firm that provided cost-effective legal services to technology companies.

“I’m pleased to have Paul join Trinity’s executive team,” said Rebecca McNamara, CFO and Head of Corporate Operations at Trinity. “Paul’s broad business knowledge and legal background make him a perfect advisor for our senior team during this high growth phase.”

“I’m most excited about the ongoing organic and acquisitive growth of Trinity and the opportunity to create additional technology solutions for our clients,” said Paul R. Lucchese, General Counsel, Trinity Life Sciences. “The potential to offer additional value to our life sciences clients through technology solutions that will allow them to bring life-changing products to market in a more efficient and effective way is a motivation for me.”

Mr. Lucchese holds an MBA from Suffolk University, a JD from the University of Dayton School of Law and a BA from Providence College.

“The Trinity team is a collection of highly intelligent people who are acutely aware of the opportunities in front of them,” continued Mr. Lucchese. “I am already thriving on this energy.”

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom